IRIS
NECCHI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.213
NA - Nord America 1.195
AS - Asia 324
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 8
AF - Africa 6
OC - Oceania 4
Totale 2.758
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.188
SE - Svezia 896
SG - Singapore 168
IT - Italia 135
CN - Cina 90
FI - Finlandia 61
DE - Germania 55
IN - India 43
IE - Irlanda 30
EU - Europa 8
GB - Regno Unito 8
CA - Canada 6
ES - Italia 6
HK - Hong Kong 5
PL - Polonia 5
IR - Iran 4
JP - Giappone 4
NL - Olanda 4
AU - Australia 3
PE - Perù 3
BE - Belgio 2
CO - Colombia 2
CZ - Repubblica Ceca 2
FR - Francia 2
GR - Grecia 2
ID - Indonesia 2
IL - Israele 2
KE - Kenya 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
VN - Vietnam 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BR - Brasile 1
KR - Corea 1
KZ - Kazakistan 1
LT - Lituania 1
MX - Messico 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
UA - Ucraina 1
Totale 2.758
Salva come PNG Salva come JPEG
Città #
Lawrence 302
Princeton 302
Ashburn 147
New York 109
Shanghai 63
Helsinki 61
Boardman 58
Milan 42
Singapore 35
Rome 31
Dublin 30
Pune 20
Hanover 10
Washington 10
Los Angeles 7
Seattle 7
Cologne 5
Mumbai 5
Borås 4
Burari 4
Chandigarh 4
Chyliczki 4
Dresden 4
Vaprio d'Adda 4
Vazzola 4
Bilbao 3
Frankfurt am Main 3
Hyderabad 3
Lucca 3
Melbourne 3
Rozzano 3
The Bronx 3
Turin 3
Verona 3
Zanjan 3
Arvada 2
Azzano Decimo 2
Bogotá 2
Council Bluffs 2
Delhi 2
Detroit 2
Genoa 2
Hanoi 2
Holyhead 2
Hong Kong 2
Jakarta 2
Latina 2
Lima 2
Lissone 2
Montevideo 2
Mushin 2
Nairobi 2
Nove Sady 2
Panorama City 2
Pescara 2
Pretoria 2
Redwood City 2
Rockville 2
Silver Spring 2
Alkmaar 1
Alton 1
Amritsar 1
Astana 1
Athens 1
Baku 1
Berlin 1
Brussels 1
Buffalo 1
Calgary 1
Castagneto 1
Central District 1
Chennai 1
Colne 1
Cortenuova 1
Desio 1
Dundee 1
Forio 1
Fort Lauderdale 1
Gainesville 1
Gunzenhausen 1
Hamamatsu 1
Houston 1
Ichibancho 1
Jeddah 1
Kansas City 1
Karlsruhe 1
Kaunas 1
Larissa 1
Legnano 1
Leuven 1
Loudi 1
Majadahonda 1
Manchester 1
Mexico City 1
Middlesbrough 1
MitspeNetofa 1
Morgantown 1
Mountain View 1
Mykolayiv 1
Newcastle upon Tyne 1
Totale 1.391
Salva come PNG Salva come JPEG
Nome #
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 29
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 28
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 27
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 27
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 26
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 26
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 25
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 24
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 24
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor beta (TGF beta) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial 24
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 23
A Plea for Economically Sustainable Evidence-based Guidelines 22
Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma 21
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 21
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 21
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 21
A global approach to improving penile cancer care 20
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study 20
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 20
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors? 20
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 19
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 19
Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients 19
[The treatment of early-stage germ cell tumors of the testis (GCTT)]. [Il trattamento dei Tumori Germinali del Testicolo (TGT) in fase iniziale.] 19
A risk calculator predicting recurrence in lymph node metastatic penile cancer 19
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation 18
Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up 18
Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration 18
Re: Madhuri Koti, Molly A. Ingersoll, Shilpa Gupta, et al. Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment. Eur Urol Oncol 2020;3:622-30 18
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand? 18
Penile cancer 18
Primary Renal Tumour Response to Immunotherapy: Lessons from Metastatic Disease and Insights into Earlier Settings 18
A Combination of Cisplatin and 5-Fluorouracil With a Taxane in Patients Who Underwent Lymph Node Dissection for Nodal Metastases From Squamous Cell Carcinoma of the Penis: Treatment Outcome and Survival Analyses in Neoadjuvant and Adjuvant Settings 17
Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians 16
Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration 16
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy 16
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study) 16
Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review 16
Von Hippel-Lindau disease-associated renal cell carcinoma: a call to action 15
Brentuximab Vedotin in CD30-Expressing Germ Cell Tumors After Chemotherapy Failure 15
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma 15
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial 15
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial 15
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? 15
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma 14
Clinical Outcome in Testicular Sex Cord Stromal Tumors: Testis Sparing vs Radical Orchiectomy and Management of Advanced Disease 14
Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy 14
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 14
Targetable gene fusions and aberrations in genitourinary oncology 14
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study 14
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer 14
Molecular subtyping and immune-gene signatures identify a subset of early bladder tumors as candidates for single-agent immune-checkpoint inhibition 14
Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma 13
Teratoma With Somatic-Type Malignant Components in Germ Cell Tumors of the Testis: A Clinicopathologic Analysis of 40 Cases With Outcome Correlation 13
Combination of Paclitaxel, Cisplatin, and Gemcitabine (TPG) for Multiple Relapses or Platinum-Resistant Germ Cell Tumors: Long-Term Outcomes 13
An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis 13
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer 13
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial 13
The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification 13
Second line salvage systemic therapy for advanced penile cancer 13
Should Upper-tract Urothelial Carcinoma and Bladder Carcinoma Be Treated the Same or Different? 13
Adjuvant Systemic Therapy for High-risk Muscle-invasive Bladder Cancer After Radical Cystectomy: Current Options and Future Opportunities 13
The obesity paradox in metastatic castration-resistant prostate cancer 13
Coming of Age of Immunotherapy of Urothelial Cancer 13
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation 13
Causal contributors to tissue stiffness and clinical relevance in urology 13
Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study 12
Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer 12
Adjuvant Therapy in Nonmetastatic High-risk Kidney Cancer: Importance of the Timing of Postnephrectomy Imaging and Treatment Delivery 12
Funcion sparing surgery in uro-oncology: germ cell tumors of the testis [La chirurgia "function sparing" in urologia oncologica: tumori germinali del testicolo (TGT)] 12
Understanding the somatic-type malignant differentiation in male germ-cell cancer: A work in progress. Response to the article by Spiess et al., Malignant transformation of testicular teratoma: A chemoresistant phenotype. Urol Oncol 2008;26:595-9 12
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent 12
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 12
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma 12
Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639–41 12
Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis 12
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors 12
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 11
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression 11
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial 11
Conventional-Dose Versus High-Dose Chemotherapy As First Salvage Treatment in Male Patients With Metastatic Germ Cell Tumors: Evidence From a Large International Database 11
From the Uncertainties to the Evidence: A Brief History of Immunotherapy as Salvage Therapy for Advanced Bladder Cancer Through a Meta-analysis 11
Nomogram-based prediction of overall survival after regional lymph node dissection and the role of perioperative chemotherapy in penile squamous cell carcinoma: A retrospective multicenter study 11
Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma 11
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial 11
A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors 11
Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer 11
Evaluation of cognitive function in trials testing new-generation hormonal therapy in patients with prostate cancer: A systematic review 11
Understanding genomics and the immune environment of penile cancer to improve therapy 11
Re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55–65 11
Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now! 11
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies 11
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 10
Re: Roisin M. Connolly, John A. McCaffrey. High-Dose Chemotherapy plus Stem Cell Transplantation in Advanced Germ Cell Cancer: A Review. Eur Urol 2009;56:57-64 10
A Prognostic Model Including Pre- and Postsurgical Variables to Enhance Risk Stratification of Primary Mediastinal Nonseminomatous Germ Cell Tumors: The 27-Year Experience of a Referral Center 10
Retroperitoneal lymph node dissection with no adjuvant chemotherapy in clinical stage i nonseminomatous germ cell tumours: Long-term outcome and analysis of risk factors of recurrence 10
EARLY AND LATE HEAT-SHOCK PROTEINS IN WHEATS AND OTHER CEREAL SPECIES 10
Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 study 10
The compact muon solenoid RPC barrel detector 10
Penile cancer 10
Totale 1.548
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.583
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.583
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 5 0 0 2 2 0 0 0 2 2 0 0
2020/2021233 0 0 0 2 169 19 39 0 4 0 0 0
2021/2022270 0 53 3 101 1 8 13 10 13 11 4 53
2022/20231.668 675 354 123 38 18 233 47 94 48 5 15 18
2023/2024934 23 57 65 63 79 182 132 118 7 20 44 144
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 3.135